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Abstract
Chlamydia trachomatis infection (chlamydia) is the most prevalent sexually transmitted bacterial 
infection and causes significant reproductive morbidity in women. Little is known about how 
immunity to chlamydia develops in women, though animal models of chlamydia indicate that T-
helper type 1 (Th1) responses are important for chlamydia clearance and protective immunity, 
whereas T-helper type 2 (Th2) responses are associated with persisting infection. In chlamydia-
infected women, whether the predominant immune response is Th1- or Th2-polarizing remains 
controversial. To determine the cytokine profiles elicited by peripheral blood mononuclear cells 
(PBMCs) from chlamydia-infected women, we stimulated PBMCs with C. trachomatis elementary 
bodies and recombinant C. trachomatis Pgp3 and measured supernatant levels of select cytokines 
spanning Th1- and Th2-polarizing responses. We found that stimulated PBMCs from chlamydia-
infected women secreted cytokines that indicate strong Th1-polarizing responses, especially 
interferon-gamma, whereas Th2-polarizing cytokines were expressed at significantly lower levels. 
In chlamydia-infected women, the predominant cytokine responses elicited on stimulation of 
PBMCs with C. trachomatis antigens were Th1-polarizing, with interferon-gamma as the 
predominant cytokine.
INTRODUCTION
Chlamydia trachomatis (Ct) causes “chlamydia”, the most prevalent bacterial sexually 
transmitted infection (STI) worldwide [1], and is associated with significant reproductive 
morbidity in women [2]. A Ct vaccine is urgently needed to curb rising Ct rates, but the 
knowledge gap in our understanding of systemic immune responses in humans hinders its 
development [3]. The majority of our knowledge of immune responses to chlamydia has 
been obtained using challenge studies in animal models of urogenital chlamydia. Animal 
models demonstrate that T-helper type 1 (Th1) cells strongly correlate with immunity 
against chlamydia re-challenge, although the T-cell type responsible appears to differ by 
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species [4]. The Th1 cytokine IFN-γ plays a major role in protective immunity, although 
other cytokines are likely contributory [5]. One potential cytokine that may act in synergy 
with IFN-γ is TNF-α, which has been shown to have anti-chlamydial properties, including 
strongly accentuating the inhibitory effect of IFN-γ on Ct growth in vitro [6]. Further, in 
mice, the presence of CD4+ T-cells producing both TNF-α and IFN-γ correlated with 
protection against chlamydia challenge [7], which highlights the importance of studying 
multiple cytokines to determine the contribution of different cytokine profiles in Ct 
infection.
In humans, studies of immune responses to chlamydia are limited and the dominant Th 
response to natural Ct infection remains insufficiently understood. A small study of 
adolescent women demonstrated that IFN-γ production by CD4+ T-cells trended towards a 
reduced risk for reinfection [8]. Another study showed an increased in the frequency of IFN-
γ-producing CD4+ T-cells in women without incident CT infection compared to women 
with CT infection [9]. Further support for the protective role of IFN-γ comes from an 
immunoepidemiologic study of commercial sex workers that showed a reduced risk for 
incident Ct infection was associated with the Th1 cytokine IFN-γ and also the Th2 cytokine 
IL-13 [10]. Another study found that the predominant peripheral blood mononuclear cell 
(PBMC) response in Ct-infected women was polarized towards Th2, characterized by IL-4 
production [11]. Given the conflicting findings from these studies, the predominant response 
in Ct-infected women remains to be fully elucidated.
We previously showed in a cohort of Ct-infected women that TNF-a is the predominant Th1 
cytokine produced by peripheral CD4+ T-cells from chlamydia-infected women, not IFN-γ, 
with approximately one third of TNF-γ-positive T-cells co-expressing either IFN-γ or IL-2 
[12]. Surprisingly, IFN-γ responses were infrequent in that study, though our analysis was 
limited to CD4+ and CD8+ T-cells and only evaluated the Th1 cytokines IFN-γ, TNF-α, and 
IL-2 by intracellular cytokine staining. In this pilot study of cytokine responses in Ct-
infected women, we expand our previous cytokine evaluation to include the Th1-polarizing 
cytokine IL-12 and Th2 cytokines, and we used multiplex cytokine analysis to measure 
cytokine levels directly from supernatants collected from PBMCs stimulated with Ct 
antigens. The primary study objective was to expand our understanding of which Th 
cytokine profile (Th1 vs. Th2) is dominant in stimulated PBMCs from Ct-infected women 
and whether specific cytokines within a Th profile contributed more than others.
MATERIALS AND METHODS
Study Population and Procedures.
In this study, we evaluated cytokines in CT-infected women at an enrollment visit, which 
was part an ongoing longitudinal study that has been previously described [12]. Briefly, 
females ≥16 years of age returning to a STD clinic for treatment of a positive screening Ct 
nucleic acid amplification test were enrolled. At enrollment, participants were interviewed 
and blood was collected for isolation of PBMCs. All participants received azithromycin 1g 
for Ct treatment. The study was approved by the University of Alabama at Birmingham 
(UAB) Institutional Review Board and the Jefferson County Department of Health.
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PBMC Isolation.
PBMCs were isolated at the UAB Center for Clinical and Translational Sciences Specimen 
Processing and Analytical Nexus by centrifugation through lymphocyte separation medium 
(Mediatech, Inc, Manassas, VA). PBMCs were frozen in 1mL aliquots in 90% FBS+10% 
DMSO and cryopreserved in liquid nitrogen until used for immunological studies.
Stimulation Assays.
Thawed PBMCs were rested overnight and then 1×105 cells/well were added to a flat-
bottom 96-well culture plate in RPMI-10 media (RPMI 1640 medium containing 10% 
human AB serum, penicillin/streptomycin [50 U/mL], HEPES [25 mM] and L-glutamine 
[2mM]) in the presence of Ct antigen and 10U/ml IL-2 incubated for 72 hours at 37°C in 5% 
CO2. After 72 hours, the cells were removed by centrifugation and the supernatant was 
stored at −80°C. Ct antigens used were: recombinant Ct Pgp3 (5 μg/ml, Biorbyt, San 
Francisco, CA), formalin-fixed Ct elementary bodies (4 μg/ml, EB, pooled serotypes D, F 
and J; obtained from Dr. Richard Morrison from the University of Arkansas for Medical 
Sciences, Little Rock, AR), and phytohemagglutinin (10 μg/ml, PHA) as the positive 
control. RPMI-10 was used to determine background cytokine responses.
Multiplex Cytokine Assay.
Cytokines were measured using a validated multiplex cytokine assay, V-PLEX (Meso Scale 
Discovery [MSD], Rockville, MD), according to the manufacturer’s instructions. Briefly, 
supernatants from PMBC stimulations were added in triplicate to 96-well V-PLEX plates 
and incubated on a rotary shaker for 2 hours at room temperature. The plates were then 
washed, cytokine-specific secondary antibodies (MSD, Rockville, MD) added, incubated for 
90 minutes, washed, and read using a V-PLEX plate reader. A serial dilution of known 
cytokine standards was used to calculate the supernatant cytokine concentrations using MSD 
Discovery Workbench software (v4.0, MSD, Rockville, MD), after subtracting the 
background (blank wells). Supernatant cytokine concentrations are reported as pg/ml. 
Cytokine concentrations that were below the level of detection were replaced with the lowest 
measurable value.
Statistical analysis.
Descriptive statistics were used to summarize demographical and clinical characteristics. 
Antigen differences in frequencies of positive cytokine responses (defined as >2 standard 
deviations above the mean background [unstimulated] supernatant cytokine level) were 
evaluated by McNemar’s chi-square test. For the quantitative analysis of positive cytokine 
responses, log10-transformed cytokine levels were evaluated with mixed model analyses of 
variance with antigen as a main effect and participant as a random effect, which accounted 
for clustering of data within individual participants. Only cytokines with ≥5 positive 
responses were analyzed. Differences were considered significant at a P-value <0.05. 
Analyses were performed with SAS software, version 9.3 (SAS Institute, Cary, NC).
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RESULTS
Seventy-seven chlamydia-infected women were included in this study (Table 1). The median 
age was 22 (range 16 – 38), 96% were African American and 99% non-Hispanic. 38% used 
hormonal contraception and the median number of sex partners in the last 3 months was one 
(range 1 – 9). 51% of women had a prior history of chlamydia (based on self-report or 
review of prior Ct test results). 56% of women were asymptomatic on enrollment, and co-
infections present included bacterial vaginosis (in 23%), trichomoniasis (3%), and 
vulvovaginal candidiasis (14%).
Ct antigen stimulated PBMCs from the majority of Ct-infected women secreted the Th1-
polarizing cytokines IFN-g, TNF-α, and IL-12.
As shown in Figure 1A, the majority of women had positive Th1-polarizing IFN-g, TNF-α, 
and IL-12 responses and Th2 IL-10 responses to either Pgp3 or EB. Only one woman (1.2%) 
had a positive IL-4 response to Pgp3; all women had negative IL-4 responses to EB. Less 
than 10% of women had positive IL-13 responses. Overall, compared to Pgp3, EB-
stimulated PBMCs were significantly more likely to elicit cytokine-positive responses.
Th1-polarizing cytokines were the dominant response by stimulated PBMCs in Ct-infected 
women.
Among the positive cytokine responses, the highest levels of cytokines were seen with the 
Th1-polarizing cytokines IFN-γ and TNF-α, which were significantly elevated above 
background levels (Figure 1B). Figure 1C shows cytokine levels for each antigen after 
subtracting the background (unstimulated cells). We also found differences in cytokine 
levels based on the Ct antigen used in the PBMC stimulation. IFN-γ had the highest levels 
of all cytokines studied, and the IFN-γ level produced in response to EB stimulation was 
significantly higher than to Pgp3 (median 171,166 pg/ml vs 39,248 pg/ml, respectively, P 
<0.001). Conversely for TNF-α, Pgp3-stimulated cells produced higher TNF-α levels than 
EB (2,343 pg/ml vs 1,350 pg/ml, respectively, P = 0.002). Although the majority of women 
generated positive IL-12 responses, the magnitude of IL-12 levels were low with the 
response to EB slightly higher than Pgp3 (3 pg/ml vs 1 pg/ml, P = 0.0001).
Th2 cytokines were produced at lower levels by stimulated PBMCs than the Th1 cytokines 
IFN-γ and TNF-α. The single positive IL-4 response was ≤0.01 pg/ml. IL-10 production 
was the highest of the Th2 cytokines, with levels produced to both Ct antigens of 
approximately 43 pg/ml. IL-13 responses were infrequent but, when present, were 
approximately 15 pg/ml. IL-10 or IL-13 responses did not differ by antigen.
Given the association of IFN-γ with protection against chlamydia in animal model studies 
and several human studies, we then assessed for any correlation between the frequency or 
magnitude of secreted IFN-γ and age, presence of symptoms, a prior history of chlamydia, 
number of partners in the last 3 months, use of hormonal contraception, and presence of co-
infections. None of these factors were found to be correlated with either the frequency or 
magnitude of the IFN-γ response (data not shown).
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DISCUSSION
Our study demonstrated that, in general, Th1-polarizing cytokine responses (especially IFN-
γ and TNF-α) were produced at a higher frequency and magnitude than Th2-polarizing 
responses in stimulated PBMCs from Ct-infected women. Of the Th1-polarizing cytokines 
produced, levels were highest for IFN-γ, followed by TNF-α; IL-12 production was 
minimal. IFN-γ levels were highest when stimulated with EB, compared to Pgp3, which 
suggests that cytokine levels are related, in part, to antigen specificity (more antigens are 
present on the EB surface compared to the single recombinant antigen Pgp3). Given our 
previous finding that TNF-α, not IFN-γ, was the predominant cytokine produced by 
stimulated CD4+ T-cells [12], our current study findings suggest that in some Ct-infected 
individuals, there may be a significant contribution by other cell types to IFN-γ production, 
possibly natural killer (NK) cells. This hypothesis is further supported by a prior study 
demonstrating that Ct EB-stimulated PBMCs had high levels of IFN-γ production by NK 
cells [13]. Interestingly, another study demonstrated that NK cell function (including IFN-γ 
production) was impaired in some Ct-infected humans [14]. Together, these findings suggest 
that NK cells may contribute to IFN-γ production in some, but not all, Ct-infected 
individuals and warrants further investigation.
In our study, positive Th2 cytokines were both infrequent and secreted at low levels. Our 
results are consistent with a previous study that found IL-4 and IL-10 mRNA was produced 
at significantly lower levels than IFN-γ on stimulation with EB [15]. Our results appear 
discordant with the study by Vicetti Miguel et al., which concluded that stimulated PBMCs 
from Ct-infected women are primarily Th2-polarized [11]. An important distinction is that 
their study used intracellular cytokine staining to report a high frequency of IL-4-positive 
CD3+ proliferating cells, while our study objective was not limited to replicating CD3+ 
cells, but instead focused on measuring the increase in secreted cytokines (including IL-4) 
from stimulated PBMCs. Also, the PBMC stimulation length was different (48 hours in their 
study vs 72 hours in our study), which may also contribute to differences in cytokine levels.
Interestingly, the secretion of the Th1-polarizing cytokine IL-12 was low in our study which, 
combined with the high levels of IFN-γ produced in Ct-infected women, suggests that a 
significant contribution of IFN-γ production may occur through an IL-12-independent 
mechanism, as has been reported to occur with other intracellular pathogens [16] and may be 
NK cell-mediated [17]. This implies that Th1 polarization may occur through multiple 
mechanisms and warrants further study into how specific cell types contribute to Th1 
polarized IFN-γ production.
Our study has strengths and weaknesses. To our knowledge, this is the largest study to date 
of Th1- and Th2-polarizing cytokine responses produced by PBMCs from Ct-infected 
humans. We also used a recombinant Ct-specific protein (Pgp3) to address potential 
concerns about cytokine responses being confounded by cross-reactivity of Ct EBs (e.g. 
from Ct HSP60, etc.) or non-specific responses (e.g., from Ct LPS). We acknowledge that 
African Americans were over-represented in our study, which could limit generalizability of 
findings. We also used whole PBMCs (without monocyte depletion) in our assays and the 
contribution of non-lymphoid cells (i.e. NK cells, monocytes) to total IFN-γ production 
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remains unknown. Also, cytokine studies using stimulated PBMCs in vitro may not 
completely reflect cytokine production in the mucosal environment. Future studies involving 
depletion of specific cell-populations in both Ct-infected and Ct-negative women will be 
important in defining the contribution of Th1-polarizing cytokine production by specific 
IFN-γ-producing populations (e.g. NK cells).
In conclusion, we showed that stimulated PBMCs from Ct-infected women produce 
predominantly Th1-polarizing cytokines on exposure to Ct antigens Pgp3 and EB, but not 
Th2-polarizing cytokines. Future studies that investigate the contribution of individual cell 
populations to Th1 cytokine production are warranted.
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FIG 1. Cytokines secreted from stimulated PBMCs from Chlamydia trachomatis (Ct)-infected 
women are predominately Th1-polarizing.
PBMCs from Ct-infected women were stimulated with Ct elementary bodies (EB) and 
recombinant Ct Pgp3 and levels of six secreted cytokines, spanning Th1 and Th2 pathways, 
were measured by multiplex cytokine analysis. (A) Qualitative positive cytokine responses 
(defined as >2 standard deviations above the mean background [unstimulated] supernatant 
cytokine level) are illustrated. The majority of subjects did not elicit positive Th2 cytokines 
IL-4 and IL-13 responses. (B) Quantitative cytokine levels in unstimulated PBMCs and in 
stimulated PBMCs in those with a positive cytokine response (pg/ml). (C) Quantitative 
antigen-stimulated cytokine levels above background. The highest cytokine levels were seen 
for Th1 cytokines, especially IFN-γ, in which levels were highest with EB-stimulated 
PBMCs compared with Pgp3-stimulated PBMCs. Th2 cytokines were expressed at lower 
levels with the lowest being IL-4, in which supernatant levels of antigen-stimulated PBMCs 
were not significantly different compared to background. The horizontal lines denote the 
median cytokine level and the whiskers denote the 95% confidence interval. M, P and E 
denote media, Pgp3, and EB, respectively. Significance was evaluated by McNemar’s chi-
square or mixed model analysis of variance. Non-significant comparisons are not labeled. 
Only cytokines with ≥5 positive responses were analyzed.
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Table 1.
Study Participant Characteristics (N = 77)
Participant Characteristics, N (%)
Median age (range) 22 (16–38)
Race
 African American 74 (96%)
 Caucasian 3 (4%)
Ethnicity
 Non-Hispanic 76 (99%)
 Hispanic 1 (1%)
Hormonal contraception* 29 (38%)
Median prior sex partners Last 3 mo. (range)* 1 (1–9)
Prior Chlamydia* 39 (51%)
Asymptomatic 43 (56%)
Co-Infections
 HIV infection Excluded
 Gonorrhea Excluded
 Bacterial vaginosis 18 (23%)
 Trichomoniasis 2 (3%)
 Candidiasis 11 (14%)
*
Data missing for one participant
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